Register entry
MALLINCKRODT HOSP PRODUCTS IP LTD
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 8
- Countries
- 0
Exclusivity
Patents and exclusivities
8| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10383834 | OFIRMEVacetaminophen | use | Nov 2028 |
| 9610265 | OFIRMEVacetaminophen | use | Nov 2028 |
| 9987238 | OFIRMEVacetaminophen | use | Nov 2028 |
| 10383834*PED | OFIRMEVacetaminophen | use | May 2029 |
| 9610265*PED | OFIRMEVacetaminophen | use | May 2029 |
| 9987238*PED | OFIRMEVacetaminophen | use | May 2029 |
| 9399012 | OFIRMEVacetaminophen | use | Sept 2031 |
| 9399012*PED | OFIRMEVacetaminophen | use | Mar 2032 |
Enquiry
Common questions
- Is MALLINCKRODT HOSP PRODUCTS IP LTD FDA approved?
- MALLINCKRODT HOSP PRODUCTS IP LTD holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.